Brown-Forman Reports Sharp Q4 Profit Decline, Issues Negative FY2027 Operating Income Guidance
BFB is trading near its 52-week low of $22.61 (8.0% above the low).
Summary
Brown-Forman reported a significant 62% drop in Q4 diluted EPS and a 53% decline in reported operating income, alongside a negative outlook for fiscal year 2027 organic operating income.
Key Events · Earnings and Guidance · BFB
-
Q4 Diluted EPS Plunges
Diluted earnings per share decreased 62% to $0.12 in the fourth fiscal quarter ended April 30, 2026.
-
Q4 Operating Income Halved
Reported operating income decreased 53% to $96 million in the fourth fiscal quarter.
-
Negative FY2027 Operating Income Guidance
The company anticipates a 3% to 5% decline in organic operating income for fiscal year 2027, citing continued macroeconomic pressures.
-
Full Year Sales Decline
Reported net sales for the full fiscal year 2026 decreased 1% to $3.9 billion (flat on an organic basis).
Analysis · BFB · Manufacturing
The company's fourth-quarter results showed a substantial decline in profitability, with reported operating income down 53% and diluted earnings per share down 62%. While full-year organic net sales were flat, the outlook for fiscal year 2027 projects a further decline in organic operating income by 3% to 5%, indicating continued macroeconomic pressures and challenges in developed markets. Despite strong cash flow generation, the core business profitability and future guidance are concerning for investors.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 36.4% of the 1059 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BFB was trading at $24.42 on NYSE in the Manufacturing sector, with a market capitalization of approximately $11.5B. The 52-week trading range was $22.61 to $33.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.